RecruitingNot ApplicableNCT07273526

Adrenaline V/s Dopamine in Fuid Refractory Septic Shock

Comparison of the Efficacy of Renaline and Dopamine in the Treatment of Fluid Refractory Septic Shock in Children


Sponsor

Laiba Qamar

Enrollment

90 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study compares the efficacy of two drugs i.e Adrenaline and dopamine in fluid refractory type of septic shock which is a dreadful medical condition especially in children. The efficacy will be checked based on heart rate , GCS, capillary refill time , palpable pripheral pulse , urine output and systolic blood pressure.


Eligibility

Min Age: 1 MonthMax Age: 12 Months

Inclusion Criteria2

  • Patients of both Genders having age range between 1month and 12 years with diagnosis of fluid refractory septic shock as per operational definition.
  • \-

Exclusion Criteria6

  • Patients with
  • cardiopumonary Bypass during last 5 days
  • Chronic Systemic disease like Chronic kidney Disease , cerebral palsy, congenital heart disease
  • neuromuscular discorder
  • Metabolic disorders
  • Those who already had treatment at periphery for hypovolemia without any record of medication or sequential organ failure at presentation

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAdrenaline

The adrenaline will be given as a vasoconstrictor in the dose of 0.1-0.3ug/kg/min to the patients in group A when diagnosed with fluid refractory septic shock

DRUGDopamine

The drug dopamine will be adminitered in dose of 10-20ug/kg/min to the patients of group B when diagnosed with fluid refractory septic shock.


Locations(1)

The Children Hospital and The Institute of Child Health Faisalabad

Faisalābad, Punjab Province, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07273526


Related Trials